X

Trial Profile

PROPHYLACTIC OROPHARYNGEAL SURFACTANT FOR PRETERM INFANTS: A RANDOMISED TRIAL (THE POPART TRIAL)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Jan 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Poractant alfa (Primary)
Indications Neonatal respiratory distress syndrome
Focus Therapeutic Use
Acronyms POPART

Most Recent Events

11 Dec 2023 Status changed from recruiting to completed, as per published in the JAMA Pediatrics
11 Dec 2023 Results assessing whether giving prophylactic oropharyngeal surfactant to preterm newborns at birth would reduce the rate of intubation for respiratory failure, published in the JAMA Pediatrics
01 May 2021 As per Eudra update record, this trial has been completed in Ireland.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com